Buy & Sell Enbridge Inc (ENB) – Enbridge Inc Price Today
Aura AI Summary
Key Stats
- $124.57BMarket Cap
- EnergySector
- -5.09%3M Drawdown
- $207.65BEnterprise Value
- 4.95%Dividend Yield
- 34% Buy | 66% SellTrading Activity
- 85 daysTypical Hold Time
Enbridge Inc (ENB) is currently valued at a market capitalization of $124.57B, with an enterprise value of $207.65B. Over the past 52 weeks, Enbridge Inc has traded between a low of $43.79 and a high of $58.04, highlighting its annual price range. Over the past three months, Enbridge Inc has recorded a drawdown of -5.09%, reflecting recent price volatility. Enbridge Inc offers a dividend yield of 4.95%, with the most recent dividend of $0.97 paid on 15 May 26. On average, investors hold Enbridge Inc for approximately 85 days, indicating typical investor behavior on the platform.
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Most Recent News
Virtual assistants in retirement plans show wide performance gaps; Fidelity and Voya lead with top AI features.
Corporate Insight's report reveals significant differences in virtual assistant performance across eight retirement plan recordkeepers. Fidelity and Voya received top marks for delivering real-time account data, strong natural language processing, an...

Broadcom launches new 5G and Wi-Fi 8 platform with Samsung, expands AI and broadband tech.
Broadcom announced a partnership with Samsung to release the first integrated 5G and Wi-Fi 8 fixed wireless access platform, aiming to improve broadband reliability and efficiency. The company also introduced new Wi-Fi 8 chips for home routers and pa...

Glioblastoma multiforme market to grow 13.2% CAGR by 2036 with new therapies advancing.
The glioblastoma multiforme market is projected to grow at a 13.2% CAGR from 2026 to 2036, driven by promising late-stage therapies from companies like Avita Biomedical and Laminar Pharma. The market size was $900 million in 2025, with the US as the ...
